Please Wait.....
Report
North America Clinical Nutrition - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-06-01 I 90 Pages I Mordor Intelligence
North America Clinical Nutrition Market Analysis
The clinical nutrition market in North America is valued at USD 31.73 billion in 2025 and is projected to reach USD 42.84 billion by 2030, registering a 6.19% CAGR through the forecast period. Demographic aging, higher survival rates for chronic-disease patients, and telehealth adoption are the main growth catalysts. Remote dietitian consultations have expanded home enteral programs, while AI-based decision support is improving parenteral protocols. Regulatory modernization, such as the FDA's first full review of infant-formula nutrients since 1988, is encouraging product innovation. Supply-chain resilience also rebounded after 2023 shocks, helped by a 34% surge in fish-oil output that stabilized lipid raw-material costs, further supporting the clinical nutrition market.
North America Clinical Nutrition Market Trends and Insights
Increasing Prevalence of Chronic & Metabolic Disorders
The rise in diabetes, cardiovascular disease, and obesity is lifting baseline demand for medical nutrition therapy. Close to half of U.S. adults live with diet-related conditions requiring intensive dietary management. Specialized formulas designed for patients using GLP-1 medications address micronutrient depletion and lean-muscle loss risks, and companies are bundling these products with virtual coaching to improve adherence. Abbott and Nestle Health Science each introduced targeted lines in 2024, signaling deeper alignment between pharmaceutical and nutrition strategies. Hospitals now include nutrition screening in chronic-care pathways, acknowledging cost offsets from reduced readmissions. Consequently, the clinical nutrition market is seeing faster uptake of disease-specific enteral products in outpatient settings.
Growing Aging Population Across North America
Adults aged 65 and older are forecast to account for one-fifth of the U.S. population by 2030. Sarcopenia and dysphagia are common geriatric challenges, prompting demand for texture-modified, high-energy formulas. Ensure surpassed USD 3 billion in global sales in 2024 as older consumers increased discretionary spending on preventive nutrition. Nursing-home malnutrition prediction models can now identify at-risk residents with 90% accuracy, enabling earlier intervention. Economically, malnutrition among older adults costs the United States USD 51.3 billion each year, strengthening the case for reimbursable nutrition solutions. These trends create sustainable tailwinds for the clinical nutrition market.
Stringent Multi-Agency Regulatory Approvals
Manufacturers must navigate separate frameworks from the FDA, Health Canada, and COFEPRIS, each with unique dossiers and labeling rules. The FDA's sweeping infant-formula nutrient review adds complexity by updating quantitative targets for numerous micronutrients. Health Canada is simultaneously modernizing its special-diet regulations to close gaps exposed during the 2022 formula shortage. Divergent timelines and documentation raise launch costs and slow cross-border rollouts, constraining velocity in the clinical nutrition market.
Other drivers and restraints analyzed in the detailed report include:
High Healthcare & Insurance Spending Levels / Rising Incidence of Pre-Term Births & Pediatric Malnutrition / Misperceptions Among Clinicians & Patients /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Oral & Enteral solutions generated 53.7% of the clinical nutrition market size in 2024. Demand reflects clinicians' preference for less invasive feeding when gastrointestinal function remains intact. Telehealth monitoring platforms now allow dietitians to titrate formulas remotely, reducing hospital revisits and reinforcing payer confidence in home care. Hospitals are integrating smart pumps that transmit real-time metrics, enabling early troubleshooting and lowering aspiration pneumonia incidents.
Parenteral products represent a smaller base but are climbing at 6.4% CAGR as mixed-oil emulsions receive broad formulary acceptance. AI engines such as TPN 2.0 calculate individualized macronutrient ratios, cutting compounding errors in NICUs. Home parenteral therapy, once limited by sepsis fears, is expanding as remote monitoring and antimicrobial lock solutions improve safety. Together, these dynamics position both modalities as complementary pillars within the clinical nutrition market.
Infant Nutrition commanded 42.1% of regional sales in 2024, buoyed by ongoing formula upgrades that add lutein, DHA, choline, and human milk oligosaccharides. Regulatory scrutiny following the 2022 contamination crisis accelerated investments in redundancy and quality controls.
Disease-Specific Enteral products are forecast to outpace the overall clinical nutrition market at 7.7% CAGR. Growth stems from oncology, renal, hepatic, and diabetes-tailored formulas that align with value-based care incentives. Weight-management drives also foster GLP-1 companion drinks fortified with high leucine content. Standard enteral continues to serve broad medical-surgical wards, while total parenteral nutrition components innovate through novel trace-element blends that lower cholestasis risk.
The North America Clinical Nutrition Market is Segmented by Route of Administration (Oral, and More), Product Type (Infant, and More), Form (Powder and More), Application (Nutritional Support for Malnutrition, and More), by End User (Pediatric, and More), Distribution Channel (Hospital Pharmacies, and More), and Geography (United States, Canada, and Mexico). The Report Offers the Value (in USD Million) for the Above Segments.
List of Companies Covered in this Report:
Abbott Laboratories / Nestle / Fresenius / Danone / Baxter / B. Braun / BASF / Perrigo Company / Reckitt Benckiser Group / Mead Johnson Nutrition / Kate Farms / Ajinomoto Cambrooke / Medtrition Inc. / Hormel Health Labs / Victus / Otsuka / ICU Medical / Medline Industries / Grifols /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence Of Chronic & Metabolic Disorders
4.2.2 Growing Aging Population Across North America
4.2.3 High Healthcare & Insurance Spending Levels
4.2.4 Rising Incidence Of Pre-Term Births & Pediatric Malnutrition
4.2.5 Expansion Of Home-Enteral Programs Enabled By Telehealth
4.2.6 FDA Fast-Track Novel Lipid Emulsions Lowering Sepsis Risk
4.3 Market Restraints
4.3.1 Stringent Multi-Agency Regulatory Approvals
4.3.2 Misperceptions Among Clinicians & Patients
4.3.3 Declining Birth Rates Reducing Pediatric Addressable Base
4.3.4 Fish-Oil Supply Shocks Disrupting Lipid Raw Materials
4.4 Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value)
5.1 By Route of Administration
5.1.1 Oral & Enteral
5.1.2 Parenteral
5.2 By Product Type
5.2.1 Infant Nutrition
5.2.2 Standard Enteral Formula
5.2.3 Disease-Specific Enteral Formula
5.2.4 Total Parenteral Nutrition (TPN) Components
5.3 By Form
5.3.1 Powder
5.3.2 Liquid
5.3.3 Semi-Solid
5.4 By Application
5.4.1 Nutritional Support for Malnutrition
5.4.2 Metabolic Disorders
5.4.3 Gastrointestinal Diseases
5.4.4 Cancer
5.4.5 Neurological Diseases
5.4.6 Other Diseases
5.5 By End User
5.5.1 Pediatric
5.5.2 Adult
5.5.3 Geriatric
5.6 By Distribution Channel
5.6.1 Hospital Pharmacies
5.6.2 Retail Pharmacies
5.6.3 Online Pharmacies
5.6.4 Homecare & Specialty Clinics
5.7 Geography
5.7.1 United States
5.7.2 Canada
5.7.3 Mexico
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 Abbott Laboratories
6.3.2 Nestle Health Science
6.3.3 Fresenius Kabi
6.3.4 Danone S.A. (Nutricia)
6.3.5 Baxter International Inc.
6.3.6 B. Braun Melsungen AG
6.3.7 BASF SE
6.3.8 Perrigo Company PLC
6.3.9 Reckitt Benckiser Group plc
6.3.10 Mead Johnson Nutrition
6.3.11 Kate Farms
6.3.12 Ajinomoto Cambrooke
6.3.13 Medtrition Inc.
6.3.14 Hormel Health Labs
6.3.15 Victus Inc.
6.3.16 Otsuka Pharmaceutical
6.3.17 ICU Medical
6.3.18 Medline Industries
6.3.19 Grifols S.A.
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security